Products

Enzymes for Research, Diagnostic and Industrial Use

Rapamycin(Sirolimus)

Cat No.
CEI-0124
Description
Rapamycin(Sirolimus) can inhibit mTOR with IC50 of 0.1 nM.
CAS_No
53123-88-9
Molecular Weight
914.18
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
mTOR
Molecular Formula
C51H79NO13
Chemical Name
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-ep
Solubility
DMSO 20 mg/mL Water
In vitro
Rapamycin can potently inhibit mTOR kinase with IC50 of 0.1 nM by binding to 12-kDa FK506- and rapamycin-binding protein (FKBP12, or FKBP) and the FKBP-rapamycin binding (FRB) domain of mTOR. Rapamycin is also an immunosuppressive drug. Rapamycin induced autophagy but not apoptosis in rapamycin-sensitive malignant glioma U87-MG and T98G cells by inhibiting the function of mTOR.

For research and industrial use only, not for personal medicinal use.

Products
Online Inquiry

For research and industrial use only, not for personal medicinal use.

0
Click unfold / close
Inquiry Basket
Delete selected Quote Check Out
Decide to move out of the shopping cart?
Sure No, Back

Please choose product!

< Go Back
You have already added to buy this product